Vimarsana
Biggest News Aggregation in the World

Page 39 - Stephen Harrison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephen Harrison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephen Harrison Today - Breaking & Trending Today

Poxel SA: Poxel Announces Positive Histology Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, a Novel, Proprietary Deuterium-Stabilized R-stereoisomer of Pioglitazone - Vimarsana News

Poxel SA: Poxel Announces Positive Histology Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, a Novel, Proprietary Deuterium-Stabilized R-stereoisomer of Pioglitazone

PXL065 Phase 2 trial for the treatment of NASH met its primary efficacy endpoint for liver fat content reduction at 36-weeks for all doses. Histology findings from paired liver biopsies showed

OPINION | STEPHEN HARRISON: How to have a Marriage made in Heaven - Vimarsana News

OPINION | STEPHEN HARRISON: How to have a Marriage made in Heaven

The other day I was reading Genesis 2:24-25, God's creation of marriage. Jesus quotes it (Matthew 19:5-6) and so does Paul (Ephesians 5:31) thus affirming it as the definition of marriage.

How to have a Marriage made in Heaven - Vimarsana News

How to have a Marriage made in Heaven

The other day I was reading Genesis 2:24-25, God's creation of marriage. Jesus quotes it (Matthew 19:5-6) and so does Paul (Ephesians 5:31) thus affirming it as the definition of marriage.

In Akero Therapeutics' Phase 2b HARMONY Study, Both the 50mg and 28mg EFX Doses Achieved Statistical Significance on Primary and Secondary Histology Endpoints after 24 Weeks - Vimarsana News

In Akero Therapeutics' Phase 2b HARMONY Study, Both the 50mg and 28mg EFX Doses Achieved Statistical Significance on Primary and Secondary Histology Endpoints after 24 Weeks

50mg (41%) and 28mg (39%) groups demonstrated =1 stage improvement in fibrosis without worsening of NASH, double the placebo rate (20%) 50mg (76%) and 28mg (47%) groups demonstrated NASH resolution

Woolworths Group Limited (WOLWF) Full Year 2022 Earnings Call Transcript - Vimarsana News

Woolworths Group Limited (WOLWF) Full Year 2022 Earnings Call Transcript

Woolworths Group Limited (OTCPK:WOLWF) Full Year 2022 Earnings Conference Call August 24, 2022 8:30 PM ET Company Participants Brad Banducci – Chief Executive Officer and Managing Director...